Clinical Trial Update: Personalized DC Vaccines in Non Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update on a personalized dendritic cell vaccine for non-small cell lung cancer; the study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Personalized dendritic cell vaccine (Autologous dendritic cell vaccine pulsed with tumor antigens)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING